ÐÑÑениÑÐµÐ²Ð¸Ñ ÐебоÑÑа - Medicinski fakultet Kragujevac
ÐÑÑениÑÐµÐ²Ð¸Ñ ÐебоÑÑа - Medicinski fakultet Kragujevac
ÐÑÑениÑÐµÐ²Ð¸Ñ ÐебоÑÑа - Medicinski fakultet Kragujevac
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Personal data:<br />
Name:<br />
Nebojsa Arsenijevic<br />
Born: 08.04.1958.<br />
Position:<br />
Professor, Dean<br />
Phone: +38134306800<br />
Fax: +38134306800<br />
e_mail:<br />
nebojsa_arsenijevic@yahoo.com<br />
Education Background<br />
(Degree/Year, Institution, Field)<br />
M.D:<br />
1982/Medical Faculty, Belgrade/Medical doctor<br />
PhD :<br />
1993/Medical Faculty, <strong>Kragujevac</strong>/ Immunology<br />
Specialty:<br />
1989/University of Belgrade/Clinical Immunology<br />
Postgraduate training: 1982/Medical Faculty, Belgrade/Immunology<br />
Other study course: 2001/National Health Institute Rome and University<br />
Sapienca,International Centre for Health Management, Italia/ Master<br />
Course in Health Services Management<br />
Academic Employment<br />
(Duration/Position, Employer)<br />
Duration<br />
Position, Employer<br />
1984-1993. Assistant, Microbiology and Immunology,Medical Faculty,<br />
<strong>Kragujevac</strong><br />
1994-1998 Assistant professor, Microbiology and Immunology,Medical Faculty,<br />
<strong>Kragujevac</strong><br />
1998-2001 Associate professor, Microbiology and Immunology, Medical<br />
Faculty, <strong>Kragujevac</strong><br />
1999-2001 Associate Professor, Basic Oncology, Medical Faculty, <strong>Kragujevac</strong><br />
2001 Professor, Microbiology and Immunology, Basic Oncology, Medical<br />
Faculty <strong>Kragujevac</strong><br />
2004 Visiting professor. Medical and biomedical sciences and health<br />
management University for Peace established by United Nations,<br />
ECPD.<br />
2005 Dean, Medical Faculty, <strong>Kragujevac</strong>
Non-Academic Appointments<br />
(Duration/Position, Employer)<br />
Duration Name of university , city/country Post held<br />
From To<br />
1982 1984 Medical center <strong>Kragujevac</strong>, Military Physician<br />
Service Belgrade and Zemun,<br />
Yugoslavia.<br />
1984 1990 Oncology center, Clinical Hospital Research fellow<br />
Center, Krgujevac, Yugoslavia.<br />
1990 1996 Department of Experimental and Head of department<br />
Clinical Immunology, Clinical<br />
Hospital Center, Krgujevac,<br />
Yugoslavia.<br />
1996 2001 Institute of Public health. Head<br />
<strong>Kragujevac</strong>, Yugoslavia.<br />
1997 2000 Faculty of Medicine; University of Vice Dean<br />
<strong>Kragujevac</strong>, Yugoslavia.<br />
2002 Faculty of Medicine; University of Head<br />
<strong>Kragujevac</strong>, SCG . Department of<br />
Microbiology and immunology<br />
2002 Faculty of Medicine; University of Head<br />
<strong>Kragujevac</strong>, SCG . Department of<br />
Basic oncology<br />
2003 Faculty of Medicine; University of Head<br />
<strong>Kragujevac</strong>, SCG . Department of<br />
Immunology. Postgraduated study.<br />
2004 University for Peace established by Head<br />
United Nations, ECPD. International<br />
specialistic study of health<br />
management<br />
2002 Board for medical science.<br />
Vice president<br />
University of <strong>Kragujevac</strong>, SCG<br />
2004 Ministry for science and<br />
environment, Beograd, SCG<br />
Evaluator of projects<br />
Association<br />
1. 2001. European Macrophage Society (EMS),<br />
2. 2001. International Association for Breast Cancer Research (IABCR)<br />
Teaching experience & working as a mentor<br />
Year Master’s thesis PhD thesis<br />
1999. Predrag Đurđević: Fagocitna aktivnost Aleksandar Lj. Đukić: Sindrom X:<br />
leukocita periferne krvi tokom akutnog Povezanost metaboličkih i imunoloških<br />
infarkta miokarda. <strong>Medicinski</strong> <strong>fakultet</strong> poremećaja u sindromu endogene<br />
Univerziteta u Kragujevcu, 1999.<br />
hiperinsulinemije / rezistencije na insulin.<br />
<strong>Medicinski</strong> <strong>fakultet</strong> Univerziteta u
Kragujevcu<br />
1999. Dejan D. Baskić: Fenotipska i<br />
funkcionalna svojstva tumor-asociranih<br />
makrofaga. <strong>Medicinski</strong> <strong>fakultet</strong><br />
Univerziteta u Kragujevcu, 1999.<br />
Goran Samardzić: Spektrofotometrijski<br />
test za brzo određivanje in vitro fagocitne<br />
aktivnosti ingestijom čestica kvasca<br />
obojenih neutralnom crvenom bojom.<br />
<strong>Medicinski</strong> <strong>fakultet</strong> Univerziteta u<br />
Kragujevcu<br />
2000. Ljubiša D Aćimović: Fagocitna funkcija<br />
monocita u karcinomu dojke. <strong>Medicinski</strong><br />
<strong>fakultet</strong> u Kragujevcu, 2000.<br />
2002. Tatjana Odrljin: Identifikacija i<br />
karakterizacija heparin-vezujućih domena<br />
adhezivnih glikoproteina fibrinogena i<br />
fibrina: funkcionalni značaj u<br />
interakcijama sa ćelijama i<br />
glikoproteinima ekstraćelijskog matriksa.<br />
<strong>Medicinski</strong> <strong>fakultet</strong> u Kragujevcu, 2002.<br />
2004. Dejan D. Baskić: Funkcija monocita u<br />
karcinomu dojke: uticaj faktora aktivacije i<br />
povezanost sa serumskim tumorskim<br />
markerima. <strong>Medicinski</strong> <strong>fakultet</strong> u<br />
Kragujevcu, 2004.<br />
2011. Ana Ravić Nikolić: Uticaj<br />
fotohemoterapije na ekspresiju citokina u<br />
psorijatičnom plaku. <strong>Medicinski</strong> <strong>fakultet</strong> u<br />
Kragujevcu, 2011.<br />
2011. Gordana Radosavljević: Značaj<br />
ekspresije Galektina-3 za metastaziranje<br />
malignog melanoma miša: modulacija<br />
adhezije i ćelijske citotoksičnosti.<br />
<strong>Medicinski</strong> <strong>fakultet</strong> u Kragujevcu, 2011.<br />
Scientific projects/Clinical trials<br />
(title/financed by)<br />
From To Title of program Program director<br />
1982 1986 Immunobiology of metastasis prof dr Nikola L.<br />
Vujanović.<br />
1990 1995 Immunoregulatory disorders in<br />
prof dr Miodrag Lukić<br />
autoimmunity and immunopathology<br />
1995 1998 Integrative functions of NS prof dr Veselinka<br />
Šušić.
1995 2001 Immunomodulatory and effectors<br />
functions in immunological disorders and<br />
infections<br />
prof dr Nebojša N.<br />
Arsenijević<br />
1999 2001 Dilatations in medicine prof dr Slobodan N.<br />
Arsenijević<br />
2002 - Phagocytosis and human malignoms prof dr Nebojša N.<br />
Arsenijević<br />
2008. - Farmakološka analiza efekata biološki<br />
aktivnih supstanci na izolovane glatke<br />
mišiće gastrointestinalnog i urogenitalnog<br />
trakta<br />
2008. - Imnoregulatorne interakcije u tumorskim i<br />
autoimunskim fenomenima<br />
2008. - Centre for pre-clinical testing of active<br />
substances – CPCTAS<br />
2011 - Molekulske determinante urođene<br />
imunosti u autoimunskim bolestima i<br />
kancerogenezi.<br />
2011 - Razvoj infrastrukture za prioritetna polja<br />
nauke<br />
Prof. Dr Slobodan<br />
Janković<br />
prof dr Slobodan N.<br />
Arsenijević<br />
Prof dr Nebojša N.<br />
Arsenijević<br />
prof dr Miodrag<br />
Stojković
Journales<br />
From To Title of Journal Post held<br />
1995 1998 Medical journal Editor<br />
1998 2001 Herald Editor<br />
1998 - Medicus Editor and General<br />
manager<br />
2004 - Journal of B.U.ON. Editor<br />
2005 - Jugoslavica Physiologica et<br />
Editor<br />
Pharmacologica<br />
2012 - American Journal of Cancer Biology<br />
(AJCB)<br />
Editorial Board<br />
Members<br />
2013 - World Journal of Respirology Editorial Board<br />
Members<br />
Interests, hobbies, family<br />
Immunology, Tumor Immunology, Oncology/Literature/Married (daughter 21, son 18)<br />
Languages<br />
(Language/Fluent or Good or Elementary)<br />
Serbian<br />
English<br />
Italian<br />
Fluent<br />
Fluent<br />
Good
The list of published papers<br />
The published papers in extenso in international journals<br />
1.<br />
2.<br />
3.<br />
4.<br />
5.<br />
6.<br />
7.<br />
8.<br />
9.<br />
10.<br />
11.<br />
12.<br />
13.<br />
Nebojša N. Arsenijević, Đorđije B. Delibašić, Milutin Vlajić, Nikola L. Vujanović. Suppression<br />
of polyclonal B-cell response to pokeweed mitogen by factors released from human primary<br />
breast cancer tissue. Periodicum Biologorum 1986; 88(1):119-120.<br />
Nikola L. Vujanović, Nebojša N. Arsenijević, Milutin Vlajić. Modulation of polymorphonuclear<br />
neutrophil motility and monocot phagocytosis by factor released from human primary breast<br />
cancer tissue. Periodicum Biologorum 1986; 88(1):53-5.<br />
Đorđije B. Delibašić, Nebojša N. Arsenijević, Nikola L. Vujanović, Ivan V. Spužić. The effect<br />
of human placenta products on the in vitro response of human mononuclear leukocytes to<br />
pokeweed mitogen stimulation. Periodicum Biologorum 1986; 88(1/a):459-461.<br />
Aleksandra Lukić, Nebojša Arsenijević, Gordan Vujanić. T and B cell in periapical granuloma.<br />
Periodicum Biologorum 1987; 89:85-6.<br />
Aleksandra Lukić, Nebojša Arsenijević, Gordan Vujanić. Les cellules immunocompetens dans<br />
le granulome dentaire. Archives de L'Union Medicale Balcanique1989;25:346-8.<br />
Aleksandra Lukić, Nebojša Arsenijević, Gordan Vujanić, Zorica Ramić. Quantitative analysis<br />
of the immunocompetent cells in periapical granuloma: correlation with the histological<br />
characteristics of the lesion. Journal of endodontics 1989;16:119-122.<br />
Aleksandra Lukić, Nebojša Arsenijević, Zorica Ramić. T cell subsets in periapical granuloma.<br />
Periodicum Biologorum 1990;92:133-4.<br />
A.Lukić, N. Arsenijević, Z. Ramić. Immunopathology of the periapical granuloma formation.<br />
Giornale di Malattie Infettive e Parasitane 1990; 42:657-9.<br />
Đukić A, Bajović Lj, Arsenijević N, Samardžić G, Hadžić O, Metiljević S, Jovanović N,<br />
Vučković M, Irić V. Effect of antidiabetic therapy on phagocytic activity of adolescent diabetic<br />
blood leukocytes. Adolescent gynecology reproduction and menopause 1995: 7(4):95<br />
Živanović A, Arsenijević S, Ristić P, Andonović V, Arsenijević N. Treatment of<br />
astenozoospermic men with THYMEX-L. International Journal of Thymology 1996; 4(7):390-3.<br />
Miličić B, Marinković J, Radotić M, Jeremić B, Arsenijević N. Knowledge generating in expert<br />
systems as support of immunological investigations. Medical Informatics Europe 1997; 642-6<br />
N.N. Arsenijević, G. Samardžić, D. Baskić, N.L. Vujanović. Immunomodulatory effects of<br />
human primary breast cancer products. Breast cancer research. 1999; 183-8.<br />
N.N. Arsenijević, G. Samardžić, D. Baskić, Lj. Aćimović, M. Knežević, N.L. Vujanović. Subsets<br />
of T cell in infiltrates of mononuclear leukocytes (IMNL) in human breast carcinoma. Breast<br />
cancer research. 1999; 177-181.
14.<br />
15.<br />
16.<br />
N.N. Arsenijević, G. Samardžić, D. Baskić, Lj. Aćimović, M. Knežević, N.L. Vujanović.<br />
Correlations between histological grades and infiltrates of T and B-lymphocytes in human<br />
breast carcinoma. Breast cancer research 1999; 173-186<br />
Baskić D, Aćimović Lj, Samardžić G, Đurđević P, Đukić A. and Arsenijević N.N. The altered<br />
activation state of macrophages isolated from ascitic fluid of patients with peritoneal<br />
carcinomatosis., Archive of oncology 2000; 8(3):99-103.<br />
D. Baskić, Lj. Aćimović, G. Samardžić, N.L. Vujanović, N.N. Arsenijević. Blood monocytes and<br />
tumor-associated macrophages in human cancer: differences in activation levels. Neoplasma<br />
2001; 48(3):169-174.<br />
17. P.M. Đurđević, N.N. Arsenijević, D.D. Baskić, A.L. Đukić, S. Popović, G. Samardžić. Systemic<br />
response of peripheral blood leukocytes and their phagocytic activity during acute myocardial<br />
infarction. Experimental & Clinical Cardiology 2001; 6(3):159-166.<br />
18. Baskić D, Aćimović Lj, Đukić A, Đurđević P, Popović S, Miličić B, Labović I and Arsenijević N.<br />
Phagocytic Activity and Nitric Oxide Production of Circulating Polymorphonuclear Leukocytes<br />
from Patients with Peritoneal Carcinomatosis. Acta Oncologica 2003;42(8):846-51.<br />
19. Dejan Baskić, Ljubiša D. Aćimović i Nebojša N. Arsenijević. Fagocitna aktivnost monocita u<br />
različitim stadijumima karcinoma dojke. Med Pregl 2003;.LVI (1):103-7.<br />
20. Predrag M. Đurđević, Dejan D. Baskić, Aleksandar Lj. Đukić, S. Popović, Vladimir Lj.<br />
Jakovljević i Nebojša N. Arsenijević. Fagocitna aktivnost leukocita periferne krvi tokom<br />
akutnog infarkta miokarda. Med Pregl 2003; LVI (1):97-102.<br />
21. D. Baskic, P. Ristic, S. Pavlovic, N. Arsenijevic. Serum HER2 and CA 15-3 in breast cancer<br />
patient. Journal of BUON 2004; 9:289-294<br />
22. Baskic D, Ristic P, Matic S, Bankovic D, Popovic S, Arsenijevic N. Clinical evaluation of the<br />
simultaneous determination of CA 15-3, CA 125 and sHER2 in breast cancer. Biomarkers<br />
2007; 12 (6): 657-667<br />
23. Mensah-Brown EP, Al Rabesi Z, Shahin A, Al Shamsi M, Arsenijevic N, Hsu DK, Liu FT. and<br />
Lukic ML. Targeted disruption of the galectin-3 gene results in decreased susceptibility to<br />
multiple low dose streptozotocininduced. Clin Immunol 2009;130(1):83-8.<br />
24. Bugarcić ZD, Petrović B, Bugarcić ZM, Janković SM, Janković SV, Lukić G, Novaković M,<br />
Kostović V, Popović S, Djurdjević P, Baskić D. and Arsenijević N. Effects of cisplatin and<br />
other Pt(II) complexes on spontaneous motility of isolated human oviduct. Toxicol In Vitro<br />
2008; 22(8):1878-82.<br />
25. Djurdjevic P, Zelen I, Ristic P, Jovanovic I, Jakovljevic V, Baskic D, Popovic S. and<br />
Arsenijevic N. Oxidative stress accelerate spontaneous apoptosis of B-chronic lymphocytic<br />
leukemia lymphocytes. J BUON 2009;14(2):281-7.<br />
26. Zdravkovic N, Shahin A, Arsenijevic N, Lukic ML and Eric PK Mensah- Brown. Regulatory T<br />
cells and ST2 signaling control diabetes induction with multiple low doses of streptozotocin.<br />
Molecular Immunology 2009; 47(1):28-36.<br />
27. Lukic ML, Arsenijevic N, Mitchison NA. Inflammation at the interface of Innate and Acquired<br />
Immunity. Mol Immunol 2009; 47(1):1-2.<br />
28. Djurdjevic P, Zelen I, Ristic P, Baskic D, Popovic S. and Arsenijevic N. Role of decreased<br />
production of Interleukin-10 and Interferon Gamma in spontaneous apoptosis of B-Chronic<br />
Lymphocytic Leukemia Lymphocytes in vitro. Archives of Medical Research 2009; 40:357-63.
29. Radosavljevic G, Ljujic B, Jovanovic I, Srzentic Z, Pavlovic S, Zdravkovic N, Milovanovic M, Bankovic D,<br />
Knezevic M, Acimovic LJ, Arsenijevic N. Interleukin-17 may be a valuable serum tumour marker in<br />
patients with colorectal carcinoma. Neoplasma 2010; 57(2): 135-144.<br />
30. Volarevic V, Al-Qahtani A, Arsenijevic N, Pajovic S, Lukic ML. Interleukin-1 receptor antagonist (IL-1Ra)<br />
and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis. Autoimmunity 2010;<br />
43(4):255-263.<br />
31. Zelen I, Djurdjevic P, Popovic S, Stojanovic M, Jakovljevic V, Radivojevic S, Baskic D, Arsenijevic N.<br />
Antioxidant enzymes activities and plasma levels of oxidative stress markers in B-chronic lymphocyte<br />
leukemia patients. J BUON 2010; 15: 330-336.<br />
32. B. Ljujic, G. Radosavljevic, I. Jovanovic, S. Pavlovic, N. Zdravkovic, M. Milovanovic, Lj. Acimovic, M.<br />
Knezevic, D. Bankovic, D Zdravkovic and N. Arsenijevic. Elevated serum level of IL-23 correlates with<br />
expression of VEGF in human colorectal carcinoma. Archives of Medical Research 2010; 41:182-189.<br />
33. J. Vujić, M. Cvijović, GN. Kaluđerovic, M. Milovanović, BB. Zmejkovski, V. Volarević, N. Arsenijević, T J.<br />
Sabo, SR. Trifunović. Palladium(II) complexes with R2edda derived ligands. Part IV. O,O'-dialkyl esters of<br />
(S,S)-ethylenediamine-N,N'-di-2-(4-methyl)-pentanoic acid dihydrochloride and their palladium(II)<br />
complexes: Synthesis, characterization and in vitro antitumoral activity against chronic lymphocytic<br />
leukemia (CLL) cells. Eur J Med Chem 2010; 45(9):3601-3606.<br />
34.<br />
M. Milovanovic, V. Volarevic, A. Djekovic, B. Petrovic, N. Arsenijevic and ZD. Bugarcic. Ligand<br />
substitutions reactions and cytotoxic properties of some selected gold(III) complexes. Journal of Inorganic<br />
Biochemistry 2010; 104(9):944-949.<br />
35. S. Popovic, D. Baskic, P. Djurdjevic, I. Zelen, M. Mitovic, I. Nikolic, D. Avramovic, M. Radenkovic, N.<br />
Arsenijevic. Endoplasmic reticulum stess-associated caspases-4 and -2 mediates Korbazol-induced CLL<br />
cell apoptosis. J BUON 2010; 15:783-790.<br />
36. D. Baskic, N. Ilic, S. Popovic, P. Djurdjevic, P. Ristic, D. Avramovic, N. Arsenijevic. In vitro induction of<br />
apoptotic cell death in chronic lymphocytic leukemia by two natural products: preliminary study. J BUON<br />
2010; 15:732-739.<br />
37. V. Volarevic, M. Milovanovic, A. Djekovic, B. Petrovic, N. Arsenijevic, Z.D. Bugarcic. The cytotoxic<br />
effects of some selected gold(III) complexes on 4T1 cells and their role in the prevention of breast tumor<br />
growth in BALB/c mice. J BUON 2010; 15:768-773.<br />
38. Ravić-Nikolić A., G. Radosavljević, I. Jovanović, N. Zdravković, S. Mitrović, S. Pavlović and N.<br />
Arsenijević. Systemic photochemotherapy decrease expression of IFN-γ, IL-12p40 and IL-23p19 in<br />
psoriatic plaque. Eur J Dermatol 2011; 21(1):53-57.<br />
39. V. Volarevic, N. Arsenijevic, M.L. Lukic, M. Stojkovic. Mesenchymal Stem Cell Treatment of<br />
Complications of Diabetes Mellitus. Stem Cells 2011; 29(1):5–10<br />
40. S. Pavlovic, N. Zdravkovic, JD. Dimitrov, A. Djukic, N. Arsenijevic, TL. Vasillev, ML. Lukic. Intravenous<br />
immunoglobulins exposed to heme (heme IVIG) are more efficient than IVIG in atteuating autoimmune<br />
diabetes. Clin Immunol 2011; 138(2):162-171<br />
41. Jovanovic I, Radosavljevic G, Mitrovic M, Lisnic Juranic V, McKenzie ANJ, Arsenijevic N, Jonjic S. and<br />
Lukic ML. ST2 Deletion Enhances Innate and Acquired Immunity to Murine Mammary Carcinoma. Eur J<br />
Immunol 2011; 41(7):1902-1912.<br />
42. G. Radosavljevic, I. Jovanovic, I. Majstorovic, M. Mitrovic, V. Juranic Lisnic, N. Arsenijevic, S. Jonjic, ML.<br />
Lukic. Deletion of Galectin-3 in the host attenuates metastasis of murine melanoma by modulating tumor<br />
adhesion and NK cell activity. Clin Exp Metastasis 2011; 28(5):451-462.<br />
43. Volarevic V, Mitrovic M, Milovanovic M, Zelen I, Nikolic I, Mitrovic S, Pejnovic N, Arsenijevic N. and Lukic<br />
M. Protective role of IL-33/ST2 axis in Con A-induced hepatitis. Journal of Hepatology 2012; 56(1):26-33.<br />
44. V. Volarevic, B. Ljujic, A, Lukic, N. Arsenijevic, Stojkovic M. Human Stem Cell Research and<br />
Regenerative Medicine - Present and Future. British Medical Bulletin 2011; 99:155-168.<br />
45. M. Arsenijević, M. Milovanović, V. Volarević, A. Djeković, T. Kanjevac, N. Arsenijević, S. Đukić and ŽD.<br />
Bugarčić. Cytotoxicity of gold (III) complexes on A549 human lung carcinoma epithelial cell line. Med<br />
Chem 2012; 8(1):2-8(7).<br />
46. T. Kanjevac, M. Milovanovic, V. Volarevic, ML. Lukic, N. Arsenijevic, D. Markovic, N. Zdravkovic, Z.<br />
Tesic, A. Lukic. Cytotoxic effects of glass ionomer cements on human dental pulp stem cells correlate<br />
with fluoride release. Med Chem 2012; 8(1): 40-45(6).
47. Vujić JM, Kaluđerović GN, Milovanović M, Zmejkovski BB, Volarević V, Zivić D, Durđević P, Arsenijević<br />
N, Trifunović SR. Stereospecific ligands and their complexes. Part VII. Synthesis, characterization and in<br />
vitro antitumoral activity of platinum(II) complexes with O,O'-dialkyl esters of (S,S)-ethylenediamine-N,N'-<br />
di-2-(4-methyl)pentanoic acid. Eur J Med Chem 2011; 46(9):4559-4565.<br />
48. S. Pavlović, N. Zdravković, G. Radosavljević, N. Arsenijević, ML. Lukić, I. Jovanović. Interleukin-33/ST2:<br />
a new signaling pathway in immunity and immunopathology. Vojnosanit Pregl 2012; 69(1): 69–77.<br />
49. Volarevic V, Milovanovic M, Ljujic B, Pejnovic N, Arsenijevic N, Nilsson U, Leffler H, Lukic ML. Galectin-3<br />
deficiency prevents concanavalin A-induced hepatitis in mice. Hepatology 2012; 55(6):1954-1964.<br />
50. G. Radosavljevic, V. Volarevic, I. Jovanovic, M. Milovanovic, N. Pejnovic, N. Arsenijevic, D.K. Hsu, M.L.<br />
Lukic. The roles of Galectin-3 in autoimmunity and tumor progression. Immunol Res 2012; 52(1-2):100-<br />
110.<br />
51. M. Milovanovic, V. Volarevic, G. Radosavljevic, I. Jovanovic, N. Pejnovic, N. Arsenijevic, M. L. Lukic. IL-<br />
33/ST2 axis in inflammation and immunopathology. Immunol Res 2012; 52(1-2):89-99.<br />
52. J.M. Vujić, G.N. Kaluđerović, B.B. Zmejkovski, M. Milovanović, V. Volarević, N. Arsenijević, T.P.<br />
Stanojković, S.R. Trifunović. Stereospecific ligands and their complexes. Part X: Synthesis,<br />
characterization and in vitro antitumoral activity of platinum(IV) complexes with O,O0-dialkyl-(S,S)-<br />
ethylenediamine-N,N0-di-2-(4-methyl)pentanoate ligands. Inorganica Chimica Acta 2012; 390:123–128.<br />
53.<br />
54.<br />
55.<br />
M. Arsenijević, M. Milovanović, V. Volarević, D. Čanović, N. Arsenijević, T. Soldatović, S. Jovanović,<br />
Ž.D. Bugarčić. Cytotoxic properties of platinum(IV) and dinuclear platinum(II) complexes and their ligand<br />
substitution reactions with guanosine-50-monophosphate. Transition Met Chem 2012; 37(5):481-488.<br />
Baskic D, Vujanovic L, Arsenijevic N, Whiteside TL, Myers EN, Vujanovic NL. Suppression of natural<br />
killer-cell and dendritic-cell apoptotic tumoricidal activity in patients with head and neck cancer. Head<br />
Neck 2013; 35(3):388–398..<br />
Milovanovic M, Volarevic V, Ljujic B, Radosavljevic G, Jovanovic I, Arsenijevic N, Lukic ML. Deletion of<br />
IL-33R (ST2) Abrogates Resistance to EAE in BALB/C Miceby Enhancing Polarization of APC to<br />
Inflammatory Phenotype. Plos ONE 2012;7(9):e45225.<br />
56. M. Borovcanin, I. Jovanovic, G. Radosavljevic, S. Djukic Dejanovic, D. Bankovic, N. Arsenijevic, M.L.<br />
Lukic. Elevated serum level of type-2 cytokine and low IL-17 in psychotic episodes. Journal of Psychiatric<br />
Research 2012; 46(11):1421-1426.<br />
57. A.Volarevic, B. Ljujic, V. Volarevic, M. Milovanovic, T. Kanjevac, A. Lukic, N. Arsenijevic. A new<br />
semiquantitative method for evaluation of metastasis progression. J BUON 2012; 17:585-590.<br />
58. G. D. Radosavljević, I. P. Jovanović, T.V. Kanjevac, N.N. Arsenijević. The role of regulatory T cells in<br />
modulation of anti-tumor immune response. Srp Arh Celok Lek 2013;142(3-4):262-267.<br />
59. N. Zdravkovic, S. Pavlovic, V. Zdravkovic, N.Pejnovic, N. Arsenijevic, M.L. Lukic. ST2 gene-deletion<br />
reveals a role of Foxp3+ regulatory T cells in diabetes modulation in BALB/c mice. Translational<br />
Research 2013;161(2):118-129.<br />
60. Pejnovic N, Pantic J, Jovanovic I, Radosavljevic G, Milovanovic M, Nikolic I, Zdravkovic N, Djukic A,<br />
Arsenijevic N, Lukic M. Galectin-3 Deficiency Accelerates High-Fat Diet Induced Obesity and Amplifies<br />
Inflammation in Adipose Tissue and Pancreatic Islets. Diabetes 2013;62(6):1932-1944.<br />
61. V. Volarevic, J.M. Vujic, M. Milovanovic, T. Kanjevac, A. Volarevic, S.R. Trifunovic, N. Arsenijevic.<br />
Cytotoxic effects of palladium(II) and platinum(II) complexes with O,O'-dialkyl esters of (S,S)-<br />
ethylenediamine-N,N’-di-2-(4-methyl) pentanoic acid on human colon cancer cell lines. J BUON 2013;<br />
18(1):131-137
62. Borovcanin M, Jovanovic I, Radosavljevic G, Djukic-Dejanovic S, Stefanovic V, Arsenijevic N, Lukic ML<br />
Antipsychotics can modulate the cytokine profile in schizophrenia: attenuation of the type-2 inflammatory<br />
response. Schizophrenia Research 2013;147(1):103-109<br />
63. D.P. Dimitrijević, V.V. Glođović, G.P. Radić, S. García-Granda, L. Menéndez-Taboada, M. Milovanović, V.<br />
Volarević, N. Arsenijević, G.A. Bogdanović, S.R. Trifunović. Stereospecific ligands and their complexes.<br />
Part XV. Synthesis, characterization and cytotoxicity of novel platinum (IV) complexes with some esters of<br />
ethylenediamine-N,N0-di-S,S-(2,20-dibenzyl)acetic acid. Crystal structure of O,O0-dipropylethylenediamine-N,N0-di-S,<br />
S-(2,20-dibenzyl)acetate dihydrochloride. Inorganica Chimica Acta 2013;<br />
402:83–89.<br />
64. Jovanovic I, Pejnovic N, Radosavljevic G, Pantic J, Milovanovic M, Arsenijevic N, Lukic M. Interleukin-<br />
33/ST2 Axis Promotes Breast Cancer Growth and Metastases by Facilitating Intratumoural Accumulation<br />
of Immunosuppressive and Innate Lymphoid Cells. Int J Cancer 2013 doi: 10.1002/ijc.28481<br />
65. Ljujic B, Milovanovic M, Volarevic V, Murray B, Bugarski D, Przyborski S, Arsenijevic N, Lukic ML,<br />
Stojkovic M. Human mesenchymal stem cells creating an immunosuppressive environment and promote<br />
breast cancer in mice. Sci Rep 2013; 3:2298. doi: 10.1038/srep02298.<br />
66. Pavlovic S, Zdravkovic N, Pejnovic N, Djoumerska-Aleksieva I.K, Arsenijevic N, Vassilev T.L, Lukic M.L.<br />
Enhanced anti-diabetogenic effect of intravenous immune globulin modified by ferrous ion exposure.<br />
European Journal of Inflammation 2014; 12(1):67-76.<br />
67. V. Volarevic, S. Bojic, J. Nurkovic, A. Volarevic, B. Ljujic, N. Arsenijevic, M. Lako, M. Stojkovic. Stem<br />
Cells as New Agents for the Treatment of Infertility: Current and Future Perspectives and Challenges.<br />
BioMed Research International http://dx.doi.org/10.1155/2014/507234<br />
68. I.P. Jovanovic, G.D. Radosavljevic, B.J. Simovic Markovic, S.P. Stojanovic, S.M. Stefanovic, N.N.<br />
Pejnovic, N.N. Arsenijevic. Clinical Significance of Cyclin D1, FGF3 and p21 Protein Expression in<br />
Laryngeal Squamous Cell Carcinoma. JBUON 2014; 19(4): 944-952<br />
69. N.D. Zdravkovic, I.P. Jovanovic, G.D. Radosavljevic, A. N. Arsenijevic, N. D. Zdravkovic, S. Lj. Mitrovic,<br />
N.N. Arsenijevic. Potential Dual Immunomodulatory Role of VEGF in Ulcerative Colitis and Colorectal<br />
Carcinoma. Int J Med Sci 2014; 11(9): 936-947.<br />
70. Volarevic V, Misirkic M, Vucicevic L, Paunovic V, Simovic Markovic B, Stojanovic M, Milovanovic M,<br />
Jakovljevic V, Micic D, Arsenijevic N, Trajkovic V, Lukic ML. Metformin aggravates immune-mediated<br />
liver injury in mice. Arch Toxicol 2014; 10.1007/s00204-014-1263-1<br />
71. Volarevic V, Paunovic V, Markovic Z, Simovic Markovic B, Misirkic-Marjanovic M, Todorović Marković B,<br />
Bojic S, Vucicevic L, Jovanovic S, Arsenijevic N, Holclajtner-Antunović I, Milosavljevic M, Dramicanin M,<br />
Kravic-Stevovic T, Ciric D, Lukic ML, Trajkovic V. Large Graphene Quantum Dots Alleviate Immune-<br />
Mediated Liver Damage. ACS Nano 2014; 8(12):12098-12109.<br />
72. Volarevic V, Nurkovic J, Arsenijevic N, Stojkovic M. Concise review: therapeutic potential of<br />
mesenchymal stem cells for the treatment of acute liver failure and cirrhosis. Stem Cells 2014;<br />
32(11):2818-2823.<br />
73. Volarevic V, Markovic BS, Bojic S, Stojanovic M, Nilsson U, Leffler H, Besra GS, Arsenijevic N, Paunovic<br />
V, Trajkovic V, Lukic ML. Gal-3 regulates the capacity of dendritic cells to promote NKT cell-induced liver<br />
injury. Eur J Immunol 2014 doi: 10.1002/eji.201444849.
The published abstracts in international journals<br />
1.<br />
2.<br />
3.<br />
4.<br />
5.<br />
6.<br />
7.<br />
8.<br />
9.<br />
10.<br />
11.<br />
12.<br />
13.<br />
Arsenijević NN, Samardžić G, Aćimović Lj, Baskić D, Knežević M, Vujanović NL. Tumor<br />
grade and composition of the cellular infiltrates in human breast carcinoma: I in situ<br />
characterization of lymphocytic infiltrates. Anticancer Research 1998; 17/5C: 3822.<br />
Arsenijević NN, Samardžić G, Baskić D, Vujanović NL. Immunomodulatory effects of human<br />
primary breast cancer products. Anticancer Research 1998; 17/5C: 3823.<br />
Arsenijević NN, Samardžić G, Baskić D, Aćimović Lj, Knežević M, Vujanović NL. Correlations<br />
between histological grades and infiltrates of T and B lymphocytes in human breast<br />
carcinoma. Anticancer Research 1998; 17/5C: 3823<br />
Samardžić G, Arsenijević N, Aćimović D, Baskić D, Knežević M, Vujanović NL. Tumor grade<br />
and composition of the cellular infiltrates in human breast carcinoma: II in situ characterization<br />
of the CD4+ and CD8+ tumor infiltrating lymphocytes. Anticancer Research 1998; 17/5C:<br />
3875<br />
Nedeljković T, Baskić D, Jakovljević V, Pešic V, Arsenijević N. Prostate specific antigen:<br />
good clinical practice. Archive of Oncology 2000; 8(suppl 1): 66.<br />
Baskić D, Arsenijević NN, Aćimović Lj. Monocyte phagocytic function in patients with breast<br />
cancer during therapy. Breast Cancer Research 2001; 3(suppl 1): 3.<br />
Arsenijević NN, Baskić D, Aćimović D. Phagocytic activity of monocytes in patients with<br />
breast cancer at different clinical stage. Breast Cancer Research 2001; 3(suppl 1): 2<br />
Vukovic I, Arsenijevic N, Lackovic V. Immunocytochemical and ultrastructural analysis of<br />
aortic wall remodeling. Atherosclerosis Supplements 2007; 8(1):105-106.<br />
Vukovic I, Arsenijevic N, Lackovic V. Cytomorphological conceptions of plaque structure in<br />
atherosclerotic lesion. Atherosclerosis Supplements 2007; 8(1):80.<br />
Vukovic I, Aleksic A, Arsenijevic NN, Aleksic AA. The origin and differentiation potential of<br />
smooth muscle cells in coronary atherosclerosis. European Journal of Cardiovascular<br />
Prevention & Rehabilitation 2008; 15(1):541.<br />
Vukovic I, Aleksic A, Arsenijevic NN, Aleksic AA. The origin and differentiation potential of<br />
smooth muscle cells in coarctation of the aorta–neonatal type. European Journal of<br />
Cardiovascular Prevention & Rehabilitation 2008;15(1):244.<br />
Vukovic I, Stankovic V, Arsenijevic N. Ultrastructural analysis of morphological lesions of<br />
coronary atherosclerosis during the stage of fatty streak. Atherosclerosis Supplements 2008;<br />
9 (1):259.<br />
Vukovic I, Stankovic V, Arsenijevic N. Immunocytochemical characteristics of morphological<br />
lesions of coronary atherosclerosis during the stage of fatty streak. Atherosclerosis<br />
Supplements 2008; 9 (1):241.
The published papers in extenso in national journals<br />
1.<br />
2.<br />
3.<br />
4.<br />
Aleksandra Lukić, Nebojša Arsenijević, Gordan Vujanić. Imunokompetentne ćelije u<br />
periapikalnom granulomu I . Prisustvo i relativni odnosi T i B limfocita. Stomatološki Glasnik<br />
Srbije 1985; 32:323-8.<br />
Aleksandra Lukić, Nebojša Arsenijević, Gordan Vujanić. Imunikompetentne ćelije u<br />
periapikalnom granulomu II . Kvantitativni odnosi subpopulacija T limfocita. Stomatološki<br />
Glasnik Srbije 1987; 34:277-83.<br />
S. N. Arsenijević, N.N. Arsenijević, A. Živanović, P. Ristić. Uticaj timozina beta-4 i soksitocina<br />
na motilitet i progresivni motilitet spermatozoida obrađivanih swim down metodom. <strong>Medicinski</strong><br />
časopis podružnice SLD <strong>Kragujevac</strong>, 1995; 34:43-5.<br />
Đukić A, Bajović Lj, Metiljević S, Arsenijević N.N, Jovanović M, Spirić R, Veljković T,<br />
Davidović M, Samardžić G. Poremećaji lipida i parametri fagocitne aktivnosti mononuklearnih<br />
ćelija periferne krvi pacijenata obolelih od diabetes mellitus-a tip 2, <strong>Medicinski</strong> časopis<br />
podružnice SLD <strong>Kragujevac</strong>, 1996: 63:2<br />
5. Arsenijević N i Baskić D. Specifični antigen prostate: klinički značaj. Medicus 2000; 1(1):7-11.<br />
6.<br />
Baskić D, Đurđević P, Đukić A, Lazić I, Pavlović S i Arsenijević N. Produkcija azot<br />
monoksidau kulturi mononuklearni leukocita modulisanih solubilnim produktima tumorskih<br />
ćelija. Medicus 2001; 2(2):29-31.<br />
7.<br />
Baskić D, Aćiimović Lj, Đurđević P, Đukić A. and Arsenijević N.<br />
ćelijska smrt. Medicus 2002; 3(2):22-5.<br />
Apoptoza, programirana<br />
8.<br />
9.<br />
10.<br />
11.<br />
12.<br />
13.<br />
Snežana T. Živančević-Simonović, Aleksandar L. Đukić, Nebojša N. Arsenijević i Ljiljana A.<br />
Dimitrijević. Autoimunska bolest štitaste žlezde: patogeneza Graves-ove bolesti i Hashimoto<br />
tireoiditisa. Medicus 2003; 4(1):21-6.<br />
Pavlovic S, Baskic D, Ristic P i Arsenijevic N. HER2. Hiperekspresija na malignim celijama.<br />
Medicus 2004; 5(1):22-26<br />
Djukic A, Zivancevic-Simonovic S, Djurdjevic P, Arsenijevic N. The effect of propylthiouracil<br />
on function of phagocytic peripheral blood cells in persons with thyroid hyperfunction. Srp Arh<br />
Celok Lek 2006; 134(7-8):290-4.<br />
Baskic D, Radosavljevic G, Cokanovic V, Jevtic I, Zelen I, Popovic S, Pavlovic S. and<br />
Arsenijevic N. Serum levels of NO, IL-18 and MDA in patients with breast carcinoma.<br />
Medicus 2005; 6(2): 62-5.<br />
Baskić D, Jovanović I, Ristić P, Jakovljević V, Delibašić Đ. and Arsenijević NN.<br />
Spectrophotometric method for simultaneous detection of nitrate and nitrite. Medicus 2005;<br />
6(2):49-52.<br />
Đurđević P, Zelen I, Ristić P, Jovanović I, Jakovljević V, Baskić D, Popović S. and<br />
Arsenijević NN. Oxidative stress markers in chronic lymphocytic leukemia. Medicus 2006;<br />
7(2): 52-6.
14.<br />
15.<br />
16.<br />
17.<br />
18.<br />
19<br />
20.<br />
21.<br />
22.<br />
23.<br />
24.<br />
25.<br />
Zelen I, Đurđević P, Popović S, Radivojević S, Stojanović M, Baskić D. i Arsenijević N.<br />
Superoxide dismutase, catalase and glutathione peroxidase activities in lymphocites and in<br />
serum of patients with chronic lymphocytic leukemia. Medicus 2007;8 (2):43-8.<br />
Protrka Z, Mitrović S, Arsenijević N, Baskić D, Radosavljević G, Stanković M, Lukić G. and<br />
Arsenijević S. Expression of C-myc Proto-oncogene inpremalignant and malignant uterine<br />
cervix lesions. Medicus 2007; 8(1):15-9.<br />
Zdravković N, Pajović S, Radosavljević G, Zdravković D, Jovanović I, Popović S, Baskić D,<br />
Zdravković S. and Arsenijević N. Reducing the phagocytic ability of monocytes in patients<br />
with multiple sclerosis Ser J Exp Clin Res 2008; 9(3):89-92.<br />
Milicic V, Baskic D, Zdravkovic N and Arsenijevic N. Nitric oxide and IFN-γ plasma levels in<br />
patients with atopic dermatitis. Ser J Exp Clin Res 2008, 9 (4): 143-148.<br />
Volarevic V, Arsenijevic N, Lukic M. Interleukin 1 Receptor Antagonist and (IL-1Ra) IL-Ra<br />
Producing Mesenchymal Stem Cell in Therapy of Diabetes Mellitus. Journal of Medical<br />
Sciences 2009; 2(2): 52-60.<br />
G.D. Radosavljevic, I.P.Jovanovic, M.G. Knezevic, N.S. Zdravkovic, S.M. Pavlovic, M.L. Lukic<br />
and N.N. Arsenijevic. The role of Galectin-3 in tumour metastasis. Moscow University<br />
Chemistry Bulletin 2010; 65(3):159-164.<br />
Jovanović I, Radosavljević G, Pavlović S, Zdravković N, Martinova K, Knežević M, Živić D,<br />
Lukić ML, Arsenijević N. Th-17 cells as novel participant in immunity to breast cancer. Ser<br />
Exp Clin Res 2010; 11(1):7-17.<br />
S. Pavlovic, N. Zdravkovic, J. Dimitrov, G. Radosavljevic, I. Jovanovic, A. Djukic, N.<br />
Arsenijevic, M. Colic, T. Vassilev, M.L. Lukic. Intravenous immunoglobulin attenuates<br />
diabetes induction in mice. Serb J Exp Clin Res 2010; 11(2):59-65.<br />
O. Vrndić, S. Živančević-Simonović, M. Stanojević, Lj. Dimitrijević, A. Đukić i N. Arsenijević.<br />
Korelacija autoantitela specifičnih za tireoidnu peroksidazu određenih korišćenjem dva<br />
radioimunološka testa. Med Pregl 2010 (doi:10.2298/MPNS1002104V)<br />
V. Volarević, M. Milovanović, N. Arsenijević, M. Lukić. A new semi-quantitative method for<br />
determining liver damage after concanavalin-A administration. Ser J Exp Clin Res 2010;<br />
11(2):45-48.<br />
D. Marković, A. Milenković G. Koliakos, E. Kostidou, I. Karadžic, J. Debeljak-Martačić, V.<br />
Jokanović, T. Perić, B. Petrović, N. Arsenijević, T. Kanjevac. Potential preservation of dental<br />
pulp stem cells. Balkan Journal of Stomatology 2010; 14:4-7.<br />
Kanjevac T, Milovanović M, Volarević V, Arsenijevic N. Fluoride release from glass ionomer<br />
cements correlates with necrotic death of human dental pulp stem cells. Ser J Exp Clin Res<br />
2011; 12 (2): 67-70.<br />
26. I.P. Jovanovic, N.N. Pejnovic, G.D. Radosavljevic, N.N. Arsenijevic, M.L. Lukic. IL-33/ST2<br />
Axis in Innate and Acquired Immunity to Tumors. OncoImmunology 2012; 1(2):229-231.<br />
27.<br />
28.<br />
Jovanovic I, Radosavljevic G, Milovanovic M, Martinova K, Pejnovic N, Arsenijevic N, Lukic<br />
ML. Suppressed Innate Immune Response against Mammary Carcinoma in BALB/C Mice.<br />
Ser J Exp Clin Res 2012; 13 (2): 55-61.<br />
Radosavljević G, Jovanović I, Martinova K, Živić D, Pejnović N, Arsenijević N, Lukić M.L.<br />
Decreased NK cell cytotoxicity and increased T regulatory cells facilitate progression of<br />
metastatic murine melanoma. Serb J Exp Clin Res 2012; 13(3):85-92.<br />
29. Volarević V, Milovanović M, Djekovic A, Bugarcic Z, Arsenijevic N. Cytotoxic effects of
selected gold (III) complexes on murine BCL-1 B lineage leukemia cell line. Ser J Exp Clin<br />
Res 2012; 13(3): 99-102.<br />
30.<br />
31.<br />
32.<br />
N. N. Pejnovic, J.M. Pantic, I.P. Jovanovic, G.D. Radosavljevic, A.Lj. Djukic, N.N. Arsenijevic,<br />
M.L. Lukic. Galectin-3 is a regulator of metaflammation in adipose tissue and pancreatic islets.<br />
Adipocyte 2013; 2(4): 1–6.<br />
Pantic JM, Pejnovic NN, Radosavljevic GD, Jovanovic IP, Djukic ALJ, Arsenijevic NN, Lukic<br />
ML. Lack of ST2 enhances high-fat diet-induced visceral adiposity and inflammation in BALB/c<br />
mice. Serb J Exp Clin Res 2013; 14 (4): 155-160.<br />
Arsenijević A, Milovanović J, Stojanović B, Milovanović M, Gershwin EM, Leung P,<br />
Arsenijević N, Lukić ML. Xenobiotic induced model of primary biliary cirrhosis. Ser J Exp Clin<br />
Res 2014; 15(3):145-150.<br />
The published abstracts in national journals<br />
1.<br />
2.<br />
3.<br />
4.<br />
5.<br />
6.<br />
7.<br />
8.<br />
Azanjac P, Jorović R., Arsenijević N. Preinciziona subkutana single - dose cephtriaxon-a u<br />
profilaksi infekcije hirurške rane. Acta chirurgica Jugoslavica, Supp (I): 1996<br />
Arsenijevic NN, Baskic D, Samardzic G, Djurdjevic P, Djukic A i Acimovic DLj. Fagocitna<br />
aktivnost mononuklearnih celija u razlicitim sradijumima karcinoma dojke. XXXVIII Oktobarski<br />
zdravstveni dani, <strong>Kragujevac</strong>, 25-26 oktobar 2001; Medicus 2001; 2/2 (Supp. 1): 21.<br />
Acimovic DLj, Baskic D, Samardzic G, Djurdjevic P, Djukic A i Arsenijevic NN. Fagocitna<br />
funkcija mononuklearnih celija tokom hirurske i hemioterapije pacijenata sa karcinomima<br />
dojke. XXXVIII Oktobarski zdravstveni dani, <strong>Kragujevac</strong>, 25-26 oktobar 2001; Medicus 2001;<br />
2/2 (Supp1): 21.<br />
Baskic D, Djurdjevic P, Djukic A, Jakovljevic V, Acimovic Lj, Samardzic G. and Arsenijevic N.<br />
Nitric oxide production in cancer patients mononuclear phagocytes. Conference of the Serbian<br />
Physiological Society, Zlatibor, december 20-23, 2001; Acta Biol Med Exp 2002; 27/1 (Supp.):<br />
69.<br />
Djurdjevic P, Baskic D, Arsenijevic N, Djukic A, Popovic S, Iric-Cupic V, Andjelkovic N,<br />
Vuckovic M, Jakovljevic V, Samardzic G Peripheral blood mononuclear cells phagocytosis<br />
during acute myocardial infarction. Conference of the Serbian Physiological Society, Zlatibor,<br />
december 20-23, 2001; Acta Biol Med Exp 2002; 27/1 (Supp.): 61.<br />
Radosavljevic G, Jovanovic I, Baskic D, Lukic M, Arsenijevic N. Uloga galektina-3 u Con-A<br />
indukovanom hepatitisu. XXXII Oktobarski zdravstveni dani-sazeci radova, <strong>Medicinski</strong> casopis<br />
2007; 41(1) Supplement 1:p22<br />
Jovanovic I, Radosavljevic G, Baskic D, Lukic M, Arsenijevic N. Uloga ST2 proteina u Con-A<br />
indukovanom hepatitisu. XXXII Oktobarski zdravstveni dani- sazeci radova, <strong>Medicinski</strong><br />
casopis 2007; 41(1) Supplement 1: p23<br />
Zdravkovic N, Arsenijevic NN, Djukic A, Zivancevic-Simonovic S, Baskic D, Mladenovic V,<br />
Jovanovic I, Popovic S, Djurdjevic P, Radosavljevic G, Lukic M. Dinamika promene<br />
biohemijskih parametara glikoregulacije tokom indukcije malih, ponovljenih doza<br />
streptozotocina miseva soja C57 BL/6. XXXII Oktobarski zdravstveni dani-sazeci radova,<br />
<strong>Medicinski</strong> casopis 2007; 41(1) Supplement 1:p22
9.<br />
10.<br />
11.<br />
Đukić A, Živančević-Simonović S, Đurđević P, Baskić D, Zdravković N, Mladenović V,<br />
Jovanović I, Popović S, Radosavljević G, Arsenijević NN. Efekat propiltiouracila na funkciju<br />
fagocita periferne krvi kod osoba sa hiperfunkcijom štitaste žlezde. <strong>Medicinski</strong> časopis 2007;<br />
41(1) Supplement 1:p19.<br />
Zelen I, Đurđević P, Popović S, Radivojević S, Stojanović M, Jovanović I, Baskić D,<br />
Arsenijević N. Enzimi glutationskog ciklusa kod obolelih od hronične limfocitne leukemije.<br />
<strong>Medicinski</strong> časopis 2007; 41(1) Supplement 1:p26.<br />
N. Zdravkovic, A. Djukic, I. Jovanovic, N. Arsenijevic, M. Lukic. Regulatory mechanisms in<br />
low dose streptozotocin diabetes induction. Ser J Exp Clin Res Supplement 2008; 9(3):p104.
The international congress presentations published in extenso<br />
1.<br />
2.<br />
3.<br />
Arsenijević NN, Samardžić G, Baskić D, Vujanović NL. Immunomodulatory effects of human<br />
primary breast cancer products. In Ioannidou-Mouzaka L, Agnatis NJ, Lopez DM, eds. Breast<br />
cancer research. Bologna: Monduzzi Editore, 1999: 183-188.<br />
Arsenijević NN, Samardžić G, Baskić D, Aćimović Lj, Knežević M, Vujanović NL. Subsets of<br />
T cell in infiltrates of mononuklear leukocytes (IMNL) in human breast carcinoma. In<br />
Ioannidou-Mouzaka L, Agnatis NJ, Lopez DM, eds. Breast cancer research. Bologna:<br />
Monduzzi Editore, 1999: 177-181<br />
Arsenijević NN, Samardžić G, Baskić D, Aćimović Lj, Knežević M, Vujanović NL. Correlations<br />
between histological grades and infiltrates of T and B lymphocytes in human breast<br />
carcinoma. In Ioannidou-Mouzaka L, Agnatis NJ, Lopez DM, eds. Breast cancer research.<br />
Bologna: Monduzzi Editore, 1999: 173-176.<br />
The international congress presentations published as abstracts<br />
1.<br />
2.<br />
3.<br />
4.<br />
5.<br />
6.<br />
7.<br />
8.<br />
9.<br />
10.<br />
Aleksandra Lukić, Nebojša Arsenijević. Direct demonstration of T cells subsets in periapical<br />
granuloma by monoclonal antibodies. FDI 73 rd World Dental Congress, Belgrade 1985.<br />
Aleksandra Lukić, Nebojša Arsenijević, Gordan Vujanić. Immunocompetent cells in<br />
periapical granuloma. XIX Semaine Medicale Balkanique, Belgrade, September 1986.<br />
Resumes II (465).<br />
Nebojša N. Arsenijević, Đorđije B. Delibašić, Milutin Vlajić, Vojislav D. Miletić, Nikola L.<br />
Vujanović. Immunosuppression by fraction derived from supernatants tissue culture of human<br />
primary breast cancer. Eight European Immunology Meeting, Zagreb, September 1987.<br />
Periodicum Biologorum, Vol. 89, Suppl. 1, (189).<br />
Đorđije B. Delibašić, Nebojša N. Arsenijević, Vojislav D. Miletić, Ivan V. Spužić, Nikola L.<br />
Vujanović, Milić R. Aleksić. Immunomodulatory products of tissue culture of human placenta.<br />
Eight European Immunology Meeting, Zagreb, September 1987. Periodicum Biologorum, Vol.<br />
89, Suppl. 1, (128).<br />
Aleksandra Lukić, N. Arsenijević, G. Vujanić. T cells subsets in periapical granuloma. Eight<br />
European Immunology Meeting. Zagreb, September 1987. Periodicum Biologorum, Vol. 89,<br />
Suppl. 1, (85).<br />
Aleksandra Lukić, Nebojša Arsenijević, Zorica Ramić. T and B cell subsets in the developing<br />
human periapical lesions. 7 th International congress of immunology Berlin-West 1989 (112-8).<br />
Aleksandra Lukić, Nebojša Arsenijević, Gordan Vujanić. Immunophenotyping of lymphocytes<br />
in human chronic periapical lesion. International symposium of monoclonal and DNA probes in<br />
diagnostic and preventive medicine, Firenc 1989.<br />
Đukić A, Bajović Lj, Arsenijević N, Samardžić G, Hadžić O, Metiljević S, Jovanović M,<br />
Vučković M, Irić V. Effects of antidiabetic therapy on phagocytic activity of adolescent diabetic<br />
blood leukocytes, Adolescent gynecology reproduction and menopause, 1995: 7(4):95<br />
Đukić A, Hadžić O, Bajović Lj, Arsenijević N, Samardžić G, Metiljević S, Jovanović M,<br />
Vucković M, Irić V. Influence of antidiabetic therapy on phagocytic activity of human diabetic<br />
blood leukocytes, Acta Diabetologica, 1996, 33 (1): 75<br />
Đukić A, Bajović Lj, Arsenijević N, Samardžić G, Hadžić O, Metiljević S, Jovanović M,<br />
Vucković M, Irić V. The influence of renal failure on phagocytic activity of human diabetic<br />
blood leukocytes, 9th European Diabetic Nephropathy Study Group, Parma, Italy, may 3-4,<br />
1996: 109
11.<br />
12.<br />
13.<br />
14.<br />
15.<br />
16.<br />
17.<br />
18.<br />
Đukić A, Hadžić O, Bajović Lj, Arsenijević N, Samardžić G.Effects of antidiabetic therapy on<br />
phagocytic activity of human diabetic blood leukocytes, Abstract book of First Balkan<br />
Immunology Conference, 29.11.-02.12.1996., Belgrade: 77<br />
Đukić A, Bajović L, Arsenijević N.N, Metiljević S, Jovanović M, Spirić R, Veljković T,<br />
Samardžić G. The connection between progression of diabetic nephropathy and phagocyte<br />
activity of mononuclear peripheral blood cells of patients with non-insulin-dependent diabetes<br />
mellitus (NIDDM), 10th Meeting of European diabetic nephropathy study group, 16-17 may,<br />
1997, Bratislava, Slovak Republic:41<br />
Đukić A, Bajović L, Arsenijević N.N, Metiljević S, Jovanović M, Spirić R, Veljković T,<br />
Samardžić G. The progression of diabetic nephropathy and phagocytosis of mononuclear<br />
cells in NIDDM, 16th International diabetes federation congress, Helsinki, 20-25 July, 1997<br />
Radanović D., Đuran M., Arsenijević N., Ponticceli G., Matović Z. Preparation spectrosopes<br />
studies and antibacetricid activity of bismuth complexes with L-cysteine. IVth Greek Italian<br />
Meeting of chemistry of Biological systems and molecular chemical engineering, Torino, 1.-<br />
3.06.1996. (31).<br />
Đurđeviđ P, Arsenijević N.N, Đukić A, Radivojević S, Vučković Z, Baskić D, Popović S,<br />
Bajović Lj, Miloradović M, Vučković M, Samardžić G. Corelattion between peripheral blood<br />
polymorphonuclear cells phagocytic activity and serum-time activities of enzymatic markers of<br />
monocytyc necrosis in patients during acute myocardial infarctation. 11th Annual Meeting of<br />
Mediterranean Asociation of Cardiology and Cardiac Surgery, Montpellier,1998<br />
Arsenijević N.N, Đurđević P M, Đukić A, Radivojević S, Vučković Z, Baskić D, Popović S,<br />
Bajović Lj, Miloradović M, Vučković M, Samardžić G. Phagocytic activity of peripheral blood<br />
mononuclear cells in patients during acute myocardial infarctation. 11th Annual Meeting of<br />
Mediterranean Asociation of Cardiology and Cardiac Surgery, Montpellier,1998.<br />
N.N. Arsenijević, G.N. Samardžić, Lj.D. Aćimović, D. Baskić, M. Knežević, N.L. Vujanović.<br />
Tumor grade and composition of the cellular infiltrates in human breast carcinoma: I in situ<br />
characterization of lymphocytic infiltrates. 22nd international breast cancer research congress<br />
of the IABCR, Athens, 24-27 Septembar 1998. Anticancer Research. Vol 17, No 5C, 3822-<br />
3823, September-October 1998.<br />
N.N. Arsenijević, G.N. Samardžić, D. Baskić, N.L. Vujanović. Immunomodulatory effects of<br />
human primary breast cancer products. 22nd international breast cancer research congress of<br />
the IABCR, Athens, 24-27 Septembar 1998. Anticancer Research. Vol 17, No 5C, 3823,<br />
September-October 1998.<br />
19. N.N. Arsenijević, G.N. Samardžić, D. Baskić, Lj.D. Aćimović, M. Knežević, N.L. Vujanović.<br />
Correlations between histological grades and infiltrates of T and B lymphocytes in human<br />
breast carcinoma. 22nd international breast cancer research congress of the IABCR, Athens,<br />
24-27 Septembar 1998. Anticancer Research. Vol 17, No 5C, 3823, September-October<br />
1998.<br />
20. Samardžić GN, Arsenijević NN, Aćimović LjD, Baskić D, Knežević M, Vujanović NL. Tumor<br />
grade and composition of the cellular infiltrates in human breast carcinoma: II in situ<br />
characterization of the CD4+ and CD8+ tumor infiltrating lymphocytes. 22nd international<br />
breast cancer research congress of the IABCR, Athens, 24-27 Septembar 1998. Anticancer<br />
Research. Vol 17, No 5C, 3875, September-October 1998.<br />
21. Miličić B, Marinković J, Jeremić B, Radotić M, Arsenijević N. Radiotherapy Alone versus<br />
Combined Radiotherapy and Chemotherapy in Stages IIIa and IIIb Non-small Cell Lung<br />
Cancer: Meta-analysis Study. 9th World Congres on Medical Informatics.<br />
22. Đukić A, Bajović Lj, Arsenijević N.N. Enhanced oxidative stress in persons with<br />
hyperinsulinemia during acute myocardial infarct, 10th Balkan Congres of endocrinology,<br />
Belgrade, 1999<br />
23. D. Baskić, N.N. Arsenijević. Mononuclear pagocytes in breast cancer. 15th Annual Meeting<br />
of The European Macrophage Society (EMS), Vienna 30.08.-01.09. 2001
24. Arsenijevic NN, Ristic P, Popovic S, Jovanovic I, Jevtic A, Pavlovic S and Baskic D. Altered<br />
pattern of IFN-gamma, IL-18 and nitric oxide production in breast cancer at different clinical<br />
stage. The 3 rd International Conference on Tumor Microenvironment: Progression, Therapy<br />
and Prevention, Prague, 2004, p146<br />
25. Baskic D, Ristic P, Popovic S, Jovanovic I, Jevtic A, Pavlovic S and Arsenijevic NN.<br />
Supernatants from primary breast cancer tissue cultures induces IL-18 and nitric oxide, but<br />
not IFN-gamma production in human peripheral blood mononuclear cells in vitro. The 3 rd<br />
International Conference on Tumor Microenvironment: Progression, Therapy and Prevention,<br />
Prague, 2004, p71.<br />
26. Arsenijevic N, Baskic D, Ristic P, Popovic S, Jevtic A, Pavlovic S and Acimovic Lj.<br />
Relationship of serum HER-2, CA 15-3 and CA 125 in patients with breast cancer. 5 th<br />
Congress of B.U.ON, Belgrade, 2004, p A-5.<br />
27. Baskic D, Ristic P, Popovic S, Jevtic A, Pavlovic S and Acimovic Lj and Arsenijevic N.<br />
Significanse of increased serum level of IFN-gamma, IL-18 and nitric oxide in breast cancer<br />
patients. 5 th Congress of B.U.ON, Belgrade, 2004, p A-50.<br />
28. Radosavljevic G, Jovanovic I, Ljujic B, Pajovic S, Zdravkovic N, Zivic D, Knezevic M,<br />
Arsenijevic N, Lukic M. Deletion of Galectin-3 in vivo downregulates lung specific metastasis<br />
of melanoma cells. Eur J Immunology Supplement 1/09 2009; p728<br />
29. Jovanovic I, Radosavljevic G, Ljujic B, Pajovic S, Zdravkovic N, Knezevic M, Majstorovic I,<br />
Arsenijevic N, Colic M, Lukic M. Attenuation of primary breast tumor growth and lung<br />
metastasis in ST2 deficient mice. Eur J Immunology Supplement 1/09 2009; p727<br />
30. Pajovic S, Zdravkovic N, Radosavljevic G, Jovanovic I, Ljujic B, Djukic A, Majstorovic I,<br />
Arsenijevic N, Colic M, Vassiliev C, Lukic M. Intravenous immunoglobulins attenuate<br />
diabetes induction in mice. Eur J Immunology Supplement 1/09 2009; p671<br />
Radosavljevic G, Jovanovic I, Majstorovic I, Arsenijevic N, Lukic ML. Galectin-3 deletion<br />
enhances anti-tumor immunity in malignant melanoma model. 97t EFIS-EJI Tatra Immunology<br />
31.<br />
Conference Molecular Determinants of T cell Immunity. Štrbské Pleso (Tatra Mountains),<br />
Slovakia, Abstract Book 2010; p45.<br />
I. Jovanovic, V. Juranic Lisnic, G. Radosavljevic, M. Mitrovic, N. Arsenijevic, S. Jonjic, M.<br />
32. Lukic. Modulation of NK phenotype by deletion of ST2 receptor. 12th Meeting of the Society<br />
for Natural Immunity. Dubrovnik-Cavtat, Croatia 2010; p113.<br />
G. Radosavljevic, M. Mitrovic, I. Jovanovic, V. Juranic Lisnic, N. Arsenijevic, S. Jonjic, A.<br />
33. Krmpotic, D. Hsu, M. Lukic. Galectin-3 deletion modulate NK cell activation. 12th Meeting of<br />
the Society for Natural Immunity. Dubrovnik-Cavtat, Croatia 2010; p122.<br />
34.<br />
35.<br />
36.<br />
Мilovanovic M, Vassilev Tch, IvanovJ, Arsenijevic N and Lukic ML. Heme exposed IvIgs<br />
enhances their downregulatory capacity in EAE. 7th International congress on autoimmunity,<br />
Ljubljana Slovenia, May 2010.<br />
Milovanović M, Volarević V, Vujić J, Trifunović S, Arsenijevic N. In vitro activity of Platinum<br />
(II) complex with O,O'-diethyl ester of (S,S)-etilendiamine-N,N'-di- 2(4-methyl) pentanoic acid<br />
on CLL cells. Preclinical Testing of Active Substances and Cancer Research with International<br />
Symposium on Anti-cancer Agents, Cardiotoxicity and Neurotoxicity, March 16-19, 2011,<br />
<strong>Kragujevac</strong>, Serbia.<br />
Kanjevac T, Milovanović M, Volarević V, Arsenijevic N. Cts of glass ionomer cements on<br />
human pulp derived mesenchymal stem cells. Preclinical Testing of Active Substances and<br />
Cancer Research with International Symposium on Anti-cancer Agents, Cardiotoxicity and<br />
Neurotoxicity, March 16-19, 2011, <strong>Kragujevac</strong>, Serbia.
37.<br />
38.<br />
39.<br />
40.<br />
41.<br />
42.<br />
43.<br />
44.<br />
45.<br />
Volarević V, Milovanović M, Djekovic A, Petrovic B, Arsenijevic N, Bugarcic Z. In vitro and in<br />
vivo antitumor activity of selected gold (III) complexes on 4T1 mouse breast cancer cell line.<br />
Preclinical Testing of Active Substances and Cancer Research with International Symposium<br />
on Anti-cancer Agents, Cardiotoxicity and Neurotoxicity, March 16-19, 2011, <strong>Kragujevac</strong>,<br />
Serbia.<br />
Baskic D, Popovic S, Zelen I, Djurdjevic P, Milovanovic M, Volarevic V, Arsenijevic N. Natural<br />
product Korbazol exerts cytotoxicity against human colon carcinoma cell lines. Preclinical<br />
Testing of Active Substances and Cancer Research with International Symposium on Anticancer<br />
Agents, Cardiotoxicity and Neurotoxicity, March 16-19, 2011, <strong>Kragujevac</strong>, Serbia.<br />
Vujić J, Kaluđerović G, Zmejkovski B, Milovanović M, Volarević V, Arsenijević N, Trifunović<br />
S; In vitro antitumoral activity of platinum (IV) complex with O,O'-dipropyl-(S,S)-<br />
ethylendiamine-N,N'-di-2(4-methylpentanoate)-ligand. Thirteenth Annual Conference<br />
YUKOMAT 2011, Herceg Novi, str. 159.<br />
Vujić J, Milovanović M, Volarević V, Arsenijević N, Trifunović S; In vitro antitumoral activity of<br />
platinum (IV) dihidrochloride, complex with O,O'-diethyl ester of (S,S)-ethylendiamine-N,N'-di-<br />
2(4-methyl) pentanoic acid. Preclinical Testing of Active Substances and Cancer Research<br />
with International Symposium on Anti-cancer Agents, Cardiotoxicity and Neurotoxicity,<br />
<strong>Kragujevac</strong>, 2011, str. 54<br />
Vujić Ј,Dimitrijević D, Milovanović M, Volarević V, Arsenijević N, Trifunović S; In vitro<br />
antitumoral activity of palladium (II) complexes with O,O'-diethyl etilendiamine-N,N'-di- (S,S)-<br />
2(4-methyl) pentanoate ligand. 7th International Confernce of the Chemical Societes of the<br />
South-Eastern European Countries Romania, 2010, str. 189<br />
Vujić J, Milovanović M, Volarević V, Arsenijević N, Trifunović S; Antitumoral activity of<br />
platinum (II) complex with O,O'-dipentyl etilendiamine-N,N'-di- (S,S)- 2(4-methyl) pentanoate<br />
ligand. 7th International Confernce of the Chemical Societes of the South-Eastern European<br />
Countries Romania, 2010, str. 190.<br />
Vujić J, Milovanović M, Volarević V, Arsenijević N, Trifunović S; Synthesis, Characterization<br />
and antitumoral activity of platinum (II) complex with O,O'-dibutyl etilendiamine-N,N'-di- (S,S)-<br />
2(4-methyl) pentanoate ligand. 7th International Conference on Nanosciences and<br />
Nanotechnologies-NN10, Ouranopolis, Halkidiki, 2010, str. 208.<br />
Vujić J, Milovanović M, Volarević V, Arsenijević N, Cvijović M, Trifunović S. Synthesis,<br />
Characterization and antitumoral activity of platinum (II) complex with O,O'-diethyl<br />
etilendiamine-N,N'-di- (S,S)- 2(4-methyl) pentanoate ligand. Eleventh Annual Conference<br />
YUKOMAT 2009, Herceg Novi, str. 191.<br />
Popovic S, Baskic D, Zelen I, Djurdjevic P, Avramovic D, Arsenijevic N. Oxidative stress and<br />
proapoptotic virtue of highly expressed Bcl-2 in Korbazol-induced apoptosis of leukemia cells.<br />
FEBS JOURNAL 2012; 279:57-57.<br />
46. Arsenijevic N, Volarevic V, Milovanovic M, Ljujic B, Pejnovic N, Nilsson U, Leffler H, Lukic M.<br />
L. The role of Galectin 3 in Con A induced liver injury. IMMUNOLOGY 2012; 137 311-311
The national congress presentations published as abstracts<br />
1.<br />
2.<br />
3.<br />
4.<br />
5.<br />
6.<br />
7.<br />
8.<br />
9.<br />
10.<br />
11.<br />
12.<br />
13.<br />
14.<br />
15.<br />
N. Arsenijević, Đ. Delibašić, N.L. Vujanović. Imunomodulatorne aktivnosti produkata humanih<br />
malignih tumora i placenti na in vitro poliklonsku stimulaciju humanih limfocita pokeweed<br />
mitogenom (PWM). XXI Kancerološka nedelja , Beograd, Novembar 1984. (30)<br />
Đ. Delibašić, N. Arsenijević, N.N. Vujanović. In vitro imunološki odgovor humanih limfocita na<br />
pokeweed mitogen (PWM); Uvodjene metode idefinisanje optimalnih uslova stimulacije<br />
stvaranja imunoglobulin-produkujućih ćelija (Ig-PĆ) i njihove detekcije pomoću<br />
imunofluorescentne metode. XXI Kancerološka nedelja, Beograd, Novembar 1984. (31)<br />
N. N. Arsenijević, Đ. B. Delibašić, M. Vlajić, N. L. VujanovIć. Imunomodulatorne aktivnosti<br />
produkata humanog karcinoma dojke. Prvi kongres imunologa Jugoslavije, Opatija, Oktobar<br />
1985. (44).<br />
N.L. Vujanović, N.N. Arsenijević, M. Vlajić. Efekti produkata himanih tumora na funkcije<br />
polimorfonuklearnih granulocita i monocita. Prvi kongres imunologa Jugoslavije, Opatija,<br />
Oktobar 1985. (196)<br />
Đ.B. Delibašić, N.N. Arsenijević, N.L. Vujanović, I. Spužić. Uticaj produkata humane placente<br />
na in vitro odgovor humanih mononuklearnih limfocita na stimulaciju pokeweed mitogenom<br />
(PWM). Prvi kongres imunologa Jugoslavije, Opatija, Oktobar 1985. (64).<br />
N.N. Arsenijević, Đ. B. Delibašić, M. Vlajić, N. L. Vujanović. Subpopulacije T limfocita u<br />
humanim karcinomima dojke . VII Kongres kancerologa Jugoslavije, Novi Sad, Oktobar 1987.<br />
(81).<br />
N. Arsenijević, Đ. Delibašić, V. Miletić, N. Vujanović. Tkivne kulture humanog karcinoma<br />
dojke produkuju imunosupresivne faktore niskih molekulskih težina. Jubilarni XV Oktobarski<br />
zdravstveni dani, <strong>Kragujevac</strong>, Oktobar 1987. (6).<br />
Delibašić Đ., N. Arsenijević, V. Miletić, N. Vujanović, I. Spužić. Izdvajanje imunomodulatornih<br />
faktora iz produkata kulture tkiva placente. Jubilarni XV oktobarski zdravstveni dani,<br />
<strong>Kragujevac</strong>, Oktobar 1987. (6).<br />
Novaković B, M. Nagulić, I. Nagulić, B. Mršulja, M. Vujadinović, J. Mojsilović, N. Arsenijević,<br />
M. Pavićević. Transplantacija nigralnog i adrenalnog tkiva u strijatum pacova- eksperimentalni<br />
model za lečenje Parkinsonove bolesti. Jubilarni XV oktobarski zdravstveni dani, <strong>Kragujevac</strong>,<br />
Oktobar 1987 (31).<br />
J. Mojsilović, N. Zečević, M. Pavićević, S. Arsenijević, B. Novaković, N. Arsenijević. Rano<br />
razviće dorzalnog thalamus-a kod čoveka, Golgi i Nissl metod. XVI oktobarski zdravstveni<br />
dani, <strong>Kragujevac</strong>, 13-15 oktobar 1988.<br />
Nebojša Arsenijević, Vojislav D. Miletić, Nikola L. Vujanović. Mehanizmi imunosupresivne<br />
aktivnosti humanog karcinoma dojke . Drugi kongres imunologa Jugoslavije, Vrnjačka Banja<br />
1989. (13.6P). (Rad je prezentiran kao plenarno izlaganje ).<br />
Aleksandra Lukić, N. Arsenijević. Subpopulacije imunikompetentnih i akcesornih ćelija u<br />
različitim tipovima periapikalnih lezija. Drugi kongres imunologa Jugoslavije, Vrnjačka banja<br />
1989. (12.14 R1).<br />
Nebojša N. Arsenijević, Goran Samardžić, Nikola Vujanović. Fenotipska analiza in situ<br />
infiltrišućih T limfocita u humanim karcinomima dojke. Prvi naučni sastanak imunologa<br />
Jugoslavije, Beograd, 1993.<br />
Miroslav Stojadinović, Goran Samardžić, Srećko Đorđević, Nebojša N. Arsenijević.<br />
Imunohistohemijska analiza infiltrišućih linfocita u tumorima prelaznog epitela. Prvi naučni<br />
sastanak imunologa Jugoslavije, Beograd, 1993.<br />
Goran Samardžić, Nebojša N. Arsenijević, Miodrag Lukić. Uticaj Ly2+ limfocita na in vivo<br />
humoralni imuni odgovor na heterologe eritrocitne antigene. Prvi naučni sastanak imunologa<br />
Jugoslavije, Beograd, 1993.
16.<br />
17.<br />
18.<br />
Lj. Aćimović, G. Samardžić, S. Gajević, S. N. Arsenijević, M. Knežević, N.N. Arsenijević.<br />
Imunohistohemijska analiza numeričkih odnosa B i T limfocita u benignim i malignim tumorima<br />
dojke. Zbornik rezimea XXII oktobarskih zdravstvenih dana, <strong>Kragujevac</strong>, 1994<br />
N.N. Arsenijević, Lj. Aćimović, G. Samardžić, S. Gajević, S. N. Arsenijević, M. Knežević.<br />
Fenotipske karakteristike TIL-T u benignim i malignim neoplazijama dojke. Zbornik rezimea<br />
XXII oktobarskih zdravstvenih dana, <strong>Kragujevac</strong>, 1994.<br />
M. Stojadinović, M. Knežević, N.N. Arsenijević. Tumor infiltrišućih limfocita u<br />
tranziciocelularnim i planocelularnim karcinomima mokraćne bešike. Zbornik rezimea XXII<br />
oktobarskih zdravstvenih dana, <strong>Kragujevac</strong>, 1994.<br />
19. N.N. Arsenijević, G. Samardžić, N. L. Vujanović. Mehanizmi imunoinhibitornih učinaka<br />
niskomolekulskih produkata tkiva karcinoma dojke. Zbornik rezimea XXII oktobarskih<br />
zdravstvenih dana, <strong>Kragujevac</strong>, 1994.<br />
20 M. Stojadinović, G. Samardžić, S. Đorđević, N.N. Arsenijević. Fenotipizacija infiltrišućih<br />
limfocita u tumorima urotela. Zbornik rezimea XXII oktobarskih zdravstvenih dana,<br />
<strong>Kragujevac</strong>, 1994.<br />
21. S.N. Arsenijević, N.N. Arsenijević, A. Živanović, P. Ristić. Uticaj timozina beta-4 i oksitocina<br />
na motilitet i progresivni motilitet spermatozoida obrađivanih swim down metodom. Zbornik<br />
rezimea XXII oktobarskih zdravstvenih dana, <strong>Kragujevac</strong>, 1994.<br />
22. N.N. Arsenijević, G. Samardžić, N.L. Vujanović. Imunomodulatorni efekti niskomolekulskih<br />
produkata tkiva humanog karcinoma dojke. Zbornik sažetaka godišnjeg sastanka udruženja<br />
alergologa i kliničkih imunologa Jugoslavije, 1994.<br />
23. Đukić A, Bajović Lj, Arsenijević N, Veljković T, Davidović M, Spirić R, Metiljević S, Jovanović<br />
M, Samardžić G. Uticaj kvaliteta liporegulacije pacijenata obolelih od NIDDM na parametre<br />
fagocitne aktivnosti mononuklearnih fagocita periferne krvi. Zbornik sažetaka, III srpski<br />
kongres o šećernoj bolesti, Beograd, 30.10.-02.11.1996. (20).<br />
24. Bajović N, Đukić A, Arsenijević N, Veljković T, Davidović M, Spirić R, Metiljević S, Jovanović<br />
M, Samardžić G. Povezanost parametara fagocitne aktivnosti mononuklearnih fagocita sa<br />
kvalitetom liporegulacije pacijenata obolelih od NIDDM. V jugoslovenski endokrinološki dani,<br />
Budva, 17.-19.04.1996. (141).<br />
25. Đukić A, Bajović Lj, Arsenijević N, Samardžić G, Hadžić O, Metiljević S, Jovanović M,<br />
Vučković M, Irić V. Uticaj antidiabetesne terapije na fagocitnu aktivnost leukocita periferne krvi<br />
dijabetičara. V jugoslovenski endokrinološki dani, Budva, 17.-19.04.1996. (138).<br />
26. Bajović Lj, Đukić A, Arsenijević N, Veljković T, Davidović M, Spirić R, Metiljević S, Jovanović<br />
M. Samardžić G. Kvalitet liporegulacije i parametri fagocitne aktivnosti mononuklearnih<br />
fagocita pacijenata obolelih od NIDDM. Zbornik sažetaka, XXIV oktobarski zdravstveni dani,<br />
<strong>Kragujevac</strong>, 24.-25.10.1996. (44).<br />
27. Đurđević P, Popović S, Baskić D, Arsenijević N, Samardžić G. Definisanje postupka obrade<br />
humanih mononuklearnih ćelija periferne krvi posle odmrzavanja. Zbornik sažetaka, XXIV<br />
oktobarski zdravstveni dani, <strong>Kragujevac</strong>, 24.-25.10.1996. (72).<br />
28. Baskić D, Đurđević P, Popović S, Arsenijević N, Samardžić G. Uticaj generatora i provodnika<br />
toplote na kriokonzervaciju humanih mononuklearnih ćelija periferne krvi. Zbornik sažetaka,<br />
XXIV oktobarski zdravstveni dani, <strong>Kragujevac</strong>, 24.-25.10.1996. (73).<br />
29. Popović S., Đurđević P., Baskić D. Arsenijević N., Samardžić G. Definisanje krioprotektora i<br />
medijuma za kriokonzervaciju humanih mononuklearnih ćelija periferne krvi. Zbornik sažetaka,<br />
XXIV oktobarski zdravstveni dani, <strong>Kragujevac</strong>, 24.-25.10.1996. (74).<br />
30. Predrag Đurđević, N.N. Arsenijević, A. Đukić, D. Baskić, M. Miloradović, G. Samardžić.<br />
Aktivnost mononuklearnih fagocita tokom lečenja aktunog infarkta miokarda trombolitičkom<br />
terapijom. XXV oktobarski zdravstveni dani, <strong>Kragujevac</strong>, 1997. (35).<br />
31. Aleksandar Đukić, N.N. Arsenijević, Lj. Bajović, M. Jovanović, S. Metiljević, G. Samardžić.<br />
Dijabetesna nefropatija i fagocitna aktivnost mononuklearnih ćelija. XXV oktobarski<br />
zdravstveni dani, <strong>Kragujevac</strong>, 1997. (34).
32. Đukić A, Bajović Lj, Arsenijeviš N.N, Đurđević P, Jovanović M, Metiljeviš, Spirić R, Veljković<br />
T. Totalni antioksidantni status, cink, malonildialdehid i azotni monoksid u osoba sa<br />
metaboličkim sindromom X i kotonarnom bplešću. Četvrti srpski kongres o šećernoj bolesti,<br />
Beograd, 1998. (93)<br />
33. Đukić A, Bajović Lj, Arsenijević N.N. Subpopulacije i funkcija mononuklearnih leukocita<br />
periferne krvi u osoba sa ishemijskom bolešću srca u zavisnosti od tolerancije glikoze i nivoa<br />
insulina,6. Kongres endokrinologa Jugoslavije, Beograd, 1999.<br />
34. Đurđević P, Arsenijević N.N,Baskić D,Vučković M, Đukić A, Irić-Ćupić V, Popović S.<br />
Fagocitna aktivnost polimorfonuklearnih leukocita periferne krvi tokom akutnog infarkta<br />
miokarda. Šesti kongres interne medicine Jugoslavije. Beograd 12-15 novembar 2000.<br />
godine. Zbornik sažetaka (49).<br />
35. Aleksandar Đukić, Bajović Lj, Arsenijević N, Đurđević P, Baskić D, Jovanović M, Metiljević S.<br />
Fagocitna aktivnost leukocita periferne krvi tokom progresije metaboličkog sindroma X u<br />
pacijenata sa koronarnom bolešću. Peti srpski kongres o šećernoj bolesti. Beograd 26-28<br />
aprila 2001 godine. Zbornik sažetaka. (38)<br />
36. N.N. Arsenijević, Baskić D, Samarđić G, Đurđević P, Đukoć A. i Aćimović D.Lj. Fagocitna<br />
aktivnost mononuklearnih ćelija u različitim stadijumima karcinoma dojke. Medicus, Vol 2<br />
(suppl. 1) (21). XXVIII Oktobarski zdravstveni dani. <strong>Kragujevac</strong> 25.-26. 10. 2001<br />
37. D.D. Baskić, P.M. Đurđević, A.Lj. Đukić, V.Lj. Jakovljević, Lj. Aćimović, G. Samarđić and N.N.<br />
Arsenijević. Nitric oxide production in cancer patients mononuclear phagocytes. Acta<br />
Biologica et Medicinae experimentalis, Vol 27 (No 1, suppl) (69) 2002. Conference of the<br />
Serbian Pysiological Society. Zlatibor 20-23, 2001.<br />
38. P.M. Đurđević, D.D. Baskić, N.N. Arsenijević, A.Lj. Đukić, S. Popović, V. Irić-Ćupić, N.V.<br />
Anđelković, M. Vučković, V.Lj. Jakovljević, G. Samarđić: Periperal blood mononuclear cells<br />
pagocytosis during acute myocardial infarction. Acta Biologica et Medicinae experimentalis,<br />
Vol 27 (No 1, suppl) (61) 2002. Conference of the Serbian Pysiological Society. Zlatibor 20-<br />
23, 2001.<br />
39. S. Popović, P.M. Đurđević, D.D. Baskić, N.N. Arsenijević, A.Lj. Đukić, V. Irić-Ćupić, N.V.<br />
Anđelković, M. Vučković, V.Lj. Jakovljević, G. Samarđić: Serum-time activities of myocardial<br />
necrosis enzymatic marcers in correlation with peripherial blood polymorphonuclear cells<br />
phagocytic activity during acute myocardial infarction. Acta Biologica et Medicinae<br />
experimentalis, Vol 27 (No 1, suppl) (61) 2002. Conference of the Serbian Pysiological<br />
Society. Zlatibor 20-23, 2001.<br />
40. Nebojša N. Arsenijević, Ivan Jovanović, Petar Ristić, Vladimir Jakovljević, Đorđije Delibašić,<br />
Dejan Baskić. Spektrofotometrijska metoda za istovremenu detekciju nitrata i nitritа, 46.<br />
kongres studenata medicine i stomatologije Srbije i Crne Gore, Kotor 2005; zbornik sažetaka<br />
p66.<br />
41. Đurđević P, Zelen I, Ristić P, Jovanović I, Jakovljević V, Baskić D, Popović S, Arsenijević N.<br />
Oxidative stress markers in chronic lymphocytic leukemia. The First Congress of Physiological<br />
Sciences of Serbia and Montenegro with International Participation-abstract book, Beograd,<br />
2005; p216.<br />
42. Jovanović I, Radosavljević G, Mitrović M, Lisnić-Juranić V, Mekenzi AN, Arsenijević N, Jonjić<br />
S, Lukić M. IL-33/ST2 signalni put u antitumorskom imunskom odgovoru-analiza u modelu<br />
mišjed tumora dojke. VI naučni sastanak Društva imunologa Srbije, Vojnomedicinska<br />
akademija, Beograd, Zbornik sažetaka 2011; p33<br />
43. Radosavljević G, Jovanović I, Majstorović I, Mitrović M, Juranić-Lisnić V, Arsenijević N, Jonjić<br />
S, Lukić M. Značaj ekspresije galektina-3 na ćelijama domaćina za metastaziranje malignog<br />
melanoma miša: modulacija adhezije tumorskih ćelija i citotoksičnosti NK ćelija. VI naučni<br />
sastanak Društva imunologa Srbije, Vojnomedicinska akademija, Beograd, Zbornik sažetaka<br />
2011; p68
Books<br />
Monographies<br />
Textbooks<br />
1.<br />
Nebojša Arsenijević, PROMETEJ ILI<br />
FAUST - BEZ ILI NIŠTA (WITHOUT OR<br />
NOTHING), poglavlje u dvojezičnoj<br />
monografiji "DILATACIJA MOGUĆEG<br />
(DILATATION OF THE POSSIBLE)",<br />
Slobodan Arsenijević, Slobodan Lazarević,<br />
Janko Đurić, Aleksandar Živanović, Vesna<br />
Stanković, Nenad Ćakić, Branislav Jeremić,<br />
Nebojša Arsenijević, Slavica Đukić Dejanović,<br />
Vidan Papić. Urednik: Slobodan Arsenijević.<br />
KBC <strong>Kragujevac</strong>. 2000-2001.<br />
Nebojša Aesenijević: IMUNSKI ODGOVOR<br />
NA INFEKTIVNE AGENSE, poglavlje u<br />
"OPŠTA BAKTERIOLOGIJA" (udžbenik za<br />
studente medicine), Nebojša Arsenijević,<br />
Olga Berger-Jekić, Miloš K. Jovanović,<br />
Branislava Kocić, Marija Kulauzov, Milena R.<br />
Nedeljković, Marica Otašević, Julijana Pecić,<br />
Lazar Ranin, Branislava Savić, Srđan<br />
Stepanović, Milena J. Švabić-Vlahović.<br />
Urednik: Miloš K. Jovanović. Savremena<br />
administracija, 1999, (103-128).<br />
2.<br />
Slobodanka Metiljević, Mihajlo Pantović,<br />
Nebojša Arsenijević i Milan Knežević:<br />
DVADESET GODINA MEDICINSKOG<br />
FAKULTETA U KRAGUJEVCU. Urednici:<br />
Srećko Đorđević i Slavoljub Stevanović.<br />
<strong>Medicinski</strong> <strong>fakultet</strong> <strong>Kragujevac</strong>. 1997.<br />
Nebojša N. Arsenijević, Dejan Baskić:<br />
"OSNOVI ONKOLOGIJE" (ZBIRKA<br />
REŠENIH PITANJA), pomoćni uđbenik za<br />
studente medicine, <strong>Medicinski</strong> <strong>fakultet</strong><br />
<strong>Kragujevac</strong>, 2000. Urednik.<br />
3.<br />
4.<br />
N. Arsenijevic, Z. Bugarcic, M. Milovanovic,<br />
V.Volarevic. Cytotoxic effects of gold (III)<br />
complexes in Encyclopedia of<br />
Metalloproteins. Springer 2013; pp<br />
922-927.<br />
Владислав Воларевић, Гордана<br />
Радосављевић, Татјана Кањевац и<br />
Небојша Арсенијевић. Вредновање<br />
научника по критеријумима Министарства<br />
Nebojša Arsenijević, OSNOVNI KURS<br />
MIKROBIOLOGIJE u "PRAKTIKUM IZ<br />
BIOHEMIJE" (skripta za studente IV godine<br />
hemije), Slavica Soluić, Nebojša Arsenijević.<br />
PMF <strong>Kragujevac</strong>. 1997.<br />
Nebojša N. Arsenijević i Goran Samarđžć<br />
IMUNOPROFILAKSA I IMUNOTERAPIJA<br />
BAKTERIJSKIH BOLESTI poglavlje u<br />
Bakteriologija. 1999.
5.<br />
6.<br />
7.<br />
8.<br />
науке. У: Вредновање науке и научника.<br />
Академија медицинских наука српског<br />
лекарског друштва и Факултет<br />
медицинских наука 2014; pp103-119.<br />
Nebojša Arsenijević: Imunski aspekti<br />
regulacionih mehanizama, poglavlje u<br />
MEHANIZMI HOMEOSTATSKE<br />
REGULACIJE (Zbirka test pitanja za<br />
postdiplomce), <strong>Medicinski</strong> <strong>fakultet</strong>,<br />
<strong>Kragujevac</strong>, 2004<br />
Nebojša Arsenijević: Imunski mehanizmi<br />
regulacije, poglavlje u OSNOVI<br />
HOMEOSTATSKE REGULACIJE, (Zbirka<br />
test pitanja), Medical faculty <strong>Kragujevac</strong>,<br />
2004.<br />
Nebojša Arsenijević: Mikrobiologija,<br />
poglavlje u PRIMARNA ZDRAVSTVENA<br />
ZAŠTITA, (Zbirka test pitanja), <strong>Medicinski</strong><br />
<strong>fakultet</strong>, <strong>Kragujevac</strong>, 2004. Urednik.<br />
Gordana Radosavljevic, Ivan Jovanovic,<br />
Jelena Pantic, Nada Pejnovic, Nebojsa<br />
Arsenijevic, Daniel K. Hsu, Miodrag L.<br />
Lukic. The role of Galectin-3 in malignant<br />
melanoma. In: A.A. Klyosov, P.G. Traber,<br />
editors. Galectins and desease. Implications<br />
for targeted therapeutics. 2012; p176-194.<br />
PhD Thesis:<br />
1. "Effects of soluble products human breast carcinoma on leukocyte function in vitro"